Karin Eastham

Companies

• Personalis (United States)Board member Sep 16, 2019 to now¹
• VERACYTE, INC.Board member Oct 29, 2013 to now²
• Geron CorporationBoard member Apr 2, 2009 to Jan 17, 2023³
• Nektar TherapeuticsBoard member Oct 1, 2018 to Sep 20, 2022⁴
• IlluminaBoard member Jun 9, 2006 to May 28, 2019⁵
• Amylin PharmaceuticalsBoard member Feb 14, 2006 to Aug 10, 2012⁶
• TercicaBoard member Jun 16, 2006 to Oct 20, 2008⁷

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• NTNektar Therapeutics NKTR23,233 shares⁸$876.3K at $37.72Sep 16, 2022
• VVERACYTE, INC. VCYT15,097 shares⁹$683.4K at $45.27Jun 18, 2026
• PUPersonalis (United States) PSNL19,756 shares¹⁰$314.7K at $15.93May 12, 2026
• Geron Corporation GERN109,047 shares¹¹$134.1K at $1.23Jan 13, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 18, 2026Sold 529 shares at $53.55 of VERACYTE, INC.⁹
• Jun 18, 2026Sold 3,200 shares at $52.78 of VERACYTE, INC.⁹
• Jun 11, 2026Granted 5,272 shares of VERACYTE, INC.¹²
• May 12, 2026Granted 6,250 shares of Personalis (United States)¹⁰
• May 12, 2026Granted 6,250 shares of Personalis (United States)¹³
• Dec 5, 2025Sold 800 shares at $46.59 of VERACYTE, INC.¹⁴
• Dec 5, 2025Sold 12,808 shares at $45.84 of VERACYTE, INC.¹⁴
• Dec 5, 2025Sold 6,392 shares at $44.52 of VERACYTE, INC.¹⁴
• Dec 5, 2025Exercised options 10,000 shares at $7.60 of VERACYTE, INC.¹⁴
• Dec 5, 2025Exercised options 10,000 shares at $7.94 of VERACYTE, INC.¹⁴
• Nov 5, 2025Sold 9,674 shares at $40.02 of VERACYTE, INC.¹⁵
• Jun 18, 2025Granted 9,321 shares of VERACYTE, INC.¹⁶
• Jun 13, 2025Sold 4,590 shares at $26.66 of VERACYTE, INC.¹⁷
• Jan 2, 2025Sold 4,691 shares at $40.50 of VERACYTE, INC.¹⁸
• Jan 2, 2025Sold 5,309 shares at $40.12 of VERACYTE, INC.¹⁸
• Jan 2, 2025Exercised options 10,000 shares at $5.28 of VERACYTE, INC.¹⁸
• Nov 19, 2024Sold 10,125 shares at $38.76 of VERACYTE, INC.¹⁹
• Nov 19, 2024Sold 3,006 shares at $37.77 of VERACYTE, INC.¹⁹
• Nov 19, 2024Sold 1,600 shares at $36.77 of VERACYTE, INC.¹⁹
• Jul 16, 2024Sold 7,500 shares at $25.00 of VERACYTE, INC.²⁰
• Jun 13, 2024Granted 11,473 shares of VERACYTE, INC.²¹
• Jun 11, 2024Sold 3,870 shares at $20.59 of VERACYTE, INC.²²
• Jun 7, 2024Sold 2,500 shares at $20.97 of VERACYTE, INC.²³
• Jun 7, 2024Exercised options 2,500 shares at $10.41 of VERACYTE, INC.²³
• Apr 1, 2024Sold 10,000 shares at $21.65 of VERACYTE, INC.²⁴